Anxiety disorders and onset of cardiovascular disease: The differential impact of panic, phobias and worry

被引:36
作者
Batelaan, Neeltje M. [1 ,2 ]
ten Have, Margreet [3 ]
van Balkom, Anton J. L. M. [1 ,2 ]
Tuithof, Marlous [3 ]
de Graaf, Ron [3 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HL Amsterdam, Netherlands
[3] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands
关键词
Anxiety disorders; Cardiovascular disease; Cohort study; Risk factor; Population study; CORONARY-HEART-DISEASE; INTERNATIONAL DIAGNOSTIC INTERVIEW; SUDDEN CARDIAC DEATH; MENTAL-HEALTH SURVEY; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; EXCESS RISK; DEPRESSION; COMORBIDITY;
D O I
10.1016/j.janxdis.2013.12.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Anxiety has been linked to onset of cardiovascular disease. This study examines the differential impact of types of anxiety (panic, phobia and worry) on 3-year onset of non-fatal cardiovascular disease (CVD). By investigating anxiety disorders as opposed to anxiety symptoms and by using a reliable diagnostic instrument to assess anxiety, limitations of previous studies are considered. 5149 persons at risk for CVD were interviewed using the Composite International Diagnostic Interview. The panic-type included panic disorder and panic attacks; the phobic-type included agoraphobia and social phobia, and the worry-type included generalized anxiety disorder. CVD was self-reported and required treatment or monitoring by a doctor. Analyses were adjusted for sociodemographics, behavioral variables, and comorbid somatic and psychiatric disorders. During follow-up, 62 persons (1.2%) developed CVD. Baseline generalized anxiety disorder was strongly associated with onset of CVD (adjusted OR: 3.39). Further research should replicate findings and focus on biological underpinnings of this association. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 65 条
  • [41] Cholesterol in mood and anxiety disorders:: review of the literature and new hypotheses
    Papakostas, GI
    Öngür, D
    Iosifescu, DV
    Mischoulon, D
    Fava, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (02) : 135 - 142
  • [42] GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome
    Parker, Gordon
    Hyett, Matthew
    Hadzi-Pavlovic, Dusan
    Brotchie, Heather
    Walsh, Warren
    [J]. PSYCHIATRY RESEARCH, 2011, 188 (03) : 383 - 389
  • [43] PHYSICAL-ACTIVITY AND PUBLIC-HEALTH - A RECOMMENDATION FROM THE CENTERS-FOR-DISEASE-CONTROL-AND-PREVENTION AND THE AMERICAN-COLLEGE-OF-SPORTS-MEDICINE
    PATE, RR
    PRATT, M
    BLAIR, SN
    HASKELL, WL
    MACERA, CA
    BOUCHARD, C
    BUCHNER, D
    ETTINGER, W
    HEATH, GW
    KING, AC
    KRISKA, A
    LEON, AS
    MARCUS, BH
    MORRIS, J
    PAFFENBARGER, RS
    PATRICK, K
    POLLOCK, ML
    RIPPE, JM
    SALLIS, J
    WILMORE, JH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05): : 402 - 407
  • [44] The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
    Penninx, Brenda W. J. H.
    Beekman, Aartjan T. F.
    Smit, Johannes H.
    Zitman, Frans G.
    Nolen, Willem A.
    Spinhoven, Philip
    Cuijpers, Pim
    De Jong, Peter J.
    Van Marwijk, Harm W. J.
    Assendelft, Willem J. J.
    Van Der Meer, Klaas
    Verhaak, Peter
    Wensing, Michel
    De Graaf, Ron
    Hoogendijk, Witte J.
    Ormel, Johan
    Van Dyck, Richard
    [J]. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2008, 17 (03) : 121 - 140
  • [45] Perk Joep, 2012, Eur Heart J, V33, P1635, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]
  • [46] Generalized Anxiety Disorder, Major Depressive Disorder, and Their Comorbidity as Predictors of All-Cause and Cardiovascular Mortality: The Vietnam Experience Study
    Phillips, Anna C.
    Batty, G. David
    Gale, Catharine R.
    Deary, Ian J.
    Osborn, David
    MacIntyre, Kate
    Carroll, Douglas
    [J]. PSYCHOSOMATIC MEDICINE, 2009, 71 (04): : 395 - 403
  • [47] Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study
    Pitsavos, C
    Panagiotakos, DB
    Papageorgiou, C
    Tsetsekou, E
    Soldatos, C
    Stefanadis, C
    [J]. ATHEROSCLEROSIS, 2006, 185 (02) : 320 - 326
  • [48] ANXIETY DISORDERS, HYPERTENSION, AND CARDIOVASCULAR RISK: A REVIEW
    Player, Marty S.
    Peterson, Lars E.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2011, 41 (04) : 365 - 377
  • [49] Depression, psychotropic medication, and risk of myocardial infarction - Prospective data from the Baltimore ECA follow-up
    Pratt, LA
    Ford, DE
    Crum, RM
    Armenian, HK
    Gallo, JJ
    Eaten, WW
    [J]. CIRCULATION, 1996, 94 (12) : 3123 - 3129
  • [50] ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069